We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug-Eluting Stent Makers Combat Fears of Clotting Risk, Weak Market Forecast
Faced with a growing threat to the $5 billion-per-year drug-eluting stent market, device manufacturers launched an information counteroffensive at a prestigious medical conference last week.